Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

Jim Manzi Biography and Net Worth

Director of Thermo Fisher Scientific

Mr. Jim P. Manzi served as the Chief Executive Officer of IBM Collaboration Solutions since April 1986 and also served as its President from October 1984 to 1995. Mr. Manzi served as the Director of Corporate Marketing at IBM Collaboration Solutions from May 1983 to September 1983 and served as its Vice President of Marketing and Sales since September 1983. He served as the Chairman, Chief Executive Officer and President of Nets Inc. He served as the Chairman of Lotus Development Corporation from July 1986 to 1995 and also served as its President from October 1984 to 1995 and Chief Executive Officer from April 1986 to 1995. He served as a Management Consultant of McKinsey & Company, where he worked extensively with Fortune 500 clients as well as offshore clients in Latin America, Europe and Asia. He has been the Chairman of the Board at Thermo Fisher Scientific, Inc. since May 2007. He has been the Chairman and Director of Fresh Direct Holdings, Inc. and Fresh Direct, LLC since March 2011. He serves as the Chairman of the Board at Skyword Inc. He has been the Chairman of StoneGate Capital Group LLC since 1995 and Thermo Electron Corp. since January 2004. He served as the Chairman of Thermo Fisher Scientific, Inc. from December 2003 to November 9, 2006 and has been its Director since May 2000. He served as the Chairman and Director of Interwise, Inc. He has been an Independent Director of Thermo Fisher Scientific, Inc. since May 2000. He has been a Director of TitBit Pte. Ltd. since September 2015, Continental Grain Company Corp. since June 2010 and Thermo Electron Corp. since May 2000. He serves as a Director of Gather, Inc. and Paxos Technology Solutions, LLC. He serves as a Trustee Emeritus of Colgate University. He serves on the Board of Brigham and Women's Hospital in Boston. He served as a Director of Partners HealthCare System, Inc. until July 2015. He served as a Director of Lotus Development Corporation. He served as a Director of Flooz.com, Inc. and SOMA Networks, Inc. He serves as a Member of Advisory Committee at Business Breakthrough, Inc. Mr. Manzi has MA in International Relations from Fletcher School and BA in Classics from the Colgate University.

What is Jim P. Manzi's net worth?: The estimated net worth of Jim P. Manzi is at least $8.52 million as of February 3rd, 2023. Mr. Manzi owns 14,807 shares of Thermo Fisher Scientific stock worth more than $8,515,506 as of April 23rd. This net worth estimate does not reflect any other investments that Mr. Manzi may own. Learn More about Jim P. Manzi's net worth.
How do I contact Jim P. Manzi?: The corporate mailing address for Mr. Manzi and other Thermo Fisher Scientific executives is 168 Third Avenue, Waltham MA, 02451. Thermo Fisher Scientific can also be reached via phone at (781) 622-1000 and via email at [email protected]. Learn More on Jim P. Manzi's contact information.
Has Jim P. Manzi been buying or selling shares of Thermo Fisher Scientific?: Jim P. Manzi has not been actively trading shares of Thermo Fisher Scientific in the last ninety days. Most recently, Jim P. Manzi sold 1,000 shares of the business's stock in a transaction on Friday, February 3rd. The shares were sold at an average price of $584.56, for a transaction totalling $584,560.00. Following the completion of the sale, the director now directly owns 14,807 shares of the company's stock, valued at $8,655,579.92. Learn More on Jim P. Manzi's trading history.
Who are Thermo Fisher Scientific's active insiders?: Thermo Fisher Scientific's insider roster includes Michael Boxer (SVP), Marc Casper (CEO), Peter Hornstra (CAO), Syed Jafry (VP), Michel Lagarde (EVP), Jim Manzi (Director), Gianluca Pettiti (EVP), Debora Spar (Director), Mark Stevenson (COO), and Stephen Williamson (CFO). Learn More on Thermo Fisher Scientific's active insiders.
Are insiders buying or selling shares of Thermo Fisher Scientific?: During the last twelve months, Thermo Fisher Scientific insiders bought shares 1 times. They purchased a total of 4 shares worth more than $2,104.60. During the last twelve months, insiders at the medical research company sold shares 14 times. They sold a total of 110,577 shares worth more than $59,726,166.22. The most recent insider tranaction occured on March, 12th when CEO Marc N Casper sold 10,000 shares worth more than $5,979,800.00. Insiders at Thermo Fisher Scientific own 0.3% of the company. Learn More about insider trades at Thermo Fisher Scientific.
Information on this page was last updated on 3/12/2024.

Jim P. Manzi Insider Trading History at Thermo Fisher Scientific

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/3/2023	Sell	1,000	$584.56	$584,560.00	14,807
8/1/2022	Sell	814	$597.24	$486,153.36	15,807
2/14/2022	Sell	1,500	$563.95	$845,925.00
7/30/2021	Sell	572	$536.54	$306,900.88
7/24/2020	Sell	3,218	$402.38	$1,294,858.84	21,803
2/5/2020	Sell	4,410	$332.32	$1,465,531.20	21,632
8/15/2019	Sell	1,833	$272.93	$500,280.69	28,592
8/18/2017	Sell	11,318	$172.94	$1,957,334.92	38,757
8/17/2017	Sell	1,000	$175.20	$175,200.00	38,757
6/3/2016	Sell	1,137	$153.00	$173,961.00	38,733
11/2/2015	Sell	3,050	$133.49	$407,144.50	38,870
5/7/2013	Sell	7,500	$82.78	$620,850.00

Jim P. Manzi Buying and Selling Activity at Thermo Fisher Scientific

Thermo Fisher Scientific Company Overview

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $575.10

$560.17

$576.69

50 Day Range

MA: $572.03

$541.78

$599.43

2 Week Range

Now: $575.10

$415.60

$603.82

Volume

2,543,876 shs

Average Volume

1,562,261 shs

Market Capitalization

$219.52 billion

P/E Ratio

37.22

Dividend Yield

0.29%

Beta

0.8